top
Search terms
Results 1 - 3 of 3 - ordered by :
Ehjcvp

Recent data from seven European countries show a much better adherence to evidence and recommendations for oral anticoagulation.1 Interestingly, NOACs were given to younger patients and only to 6% of ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Rocio Hinojar, Jose Julio Jiménez-Natcher, Covadonga Fernández-Golfín, Jose Luis Zamorano

Date : 01/04/2015 Item size : 312462 bytes
Ehjcvp

Abstract Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation (AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin. Using a ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 01/01/2017 Item size : 240628 bytes
Ehjcvp

Using a Cox proportional hazard model adjusting for baseline characteristics, use of apixaban [hazard ratio (HR) 0.70, 95% confidence interval (CI) 0.610.80, P0.001] and dabigatran (HR 0.74, 95% CI ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 27/09/2016